MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs

    S. Schaefer, Z. London, J. Ferrara, M. McCoyd, C. Cronin, E. Poole Pharr, R. Price, M. Cincotta, H. Rigby, S. Vota, M. Slade, J. Moeller (New Haven, CT, USA)

    Objective: Determine knowledge growth and resident satisfaction with an online curriculum in movement disorders across multiple programs. Background: Exposure to movement disorders in residency is…
  • MDS Virtual Congress 2020

    Parkinson’s Disease in Israel – Initial Symptoms and Comorbidities from 20 years of Follow Up in a Population-based Cohort

    Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)

    Objective: To describe the epidemiology of Parkinson’s disease (PD) in Israel during a 20-year period, 2000–2019, and to characterize initial symptoms and comorbidities of PD…
  • MDS Virtual Congress 2020

    Short- and Long-term Healthcare Resource Utilization in Parkinson’s Disease – 20 years of Follow Up in a Population-based Cohort

    Y. Barer, N. Gavrielov, I. Goldshtein, M. Martinec, I. Korolev, P. Coloma (Tel Aviv, Israel)

    Objective: To assess Parkinson’s disease (PD) burden by means of healthcare resource utilization (HCRU) and clinical outcomes in Israeli PD patients during 20-year period ,2000…
  • MDS Virtual Congress 2020

    Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank

    D. Belete, B. Jacobs, J. Bestwick, C. Blauwendraat, S. Bandres-Ciga, K. Heilbron, R. Dobson, M. Nalls, A. Singleton, J. Hardy, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To systematically investigate the association of environmental risk factors and prodromal features with incident Parkinson’s disease (PD) diagnosis and the interaction of genetic risk…
  • MDS Virtual Congress 2020

    Improving estimation of Parkinson’s disease risk – enhancing the PREDICT-PD algorithm

    J. Bestwick, S. Auger, D. Grosset, S. Kanavou, G. Giovannoni, A. Lees, J. Cuzick, C. Simonet, R. Rees, D. Rack, M. Jitlal, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To develop and test an enhanced algorithm for the prediction of Parkinson’s disease (PD) risk. Background: The PREDICT-PD algorithm estimates risk of PD using…
  • MDS Virtual Congress 2020

    Pesticide Exposure in PD with and without Genetic Risk Variants

    E. Brown, C. Meng, S. Goldman, C. Tanner (San Francisco, CA, USA)

    Objective: To evaluate the association between pesticide exposure and development of Parkinson’s disease (PD) in idiopathic and genetic PD, and to determine whether clinical features…
  • MDS Virtual Congress 2020

    Age at onset and Parkinson’s disease progression

    G. D'Urso, K. Taylor, T. Kustermann, N. Pavese, G. Pagano (Basel, Switzerland)

    Objective: Explore whether age at onset of Parkinson’s disease influences the rate of early disease progression. Background: In cross-sectional studies, older age at onset has…
  • MDS Virtual Congress 2020

    Weeding Through the Haze: A Survey on Cannabis Use Among People with Parkinson’s Disease

    M. Feeney, B. Kluger, A. Stoessl, D. Bega, S. Gilbert, A. Hosang, E. Ogren, K. Schroeder, C. Evers, J. Beck (New York, NY, USA)

    Objective: To identify themes in cannabis use among people with Parkinson’s disease to inform medical recommendations and the design of future clinical trials. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Disparities in access to care and research participation among individuals with advanced Parkinson’s Disease: Comparison of participants in a home visit model vs. national registry

    J. Fleisher, E. Klostermann, E. Myrick, D. Mitchem, J. Lee, K. Woo, B. Ouyang, N. Witek, J. Beck, D. Hall, J. Chodosh (Chicago, IL, USA)

    Objective: We sought to identify whether those with advanced Parkinson’s disease (PD) who become homebound are sociodemographically different than those who continue to attend outpatient…
  • MDS Virtual Congress 2020

    The incidence, predictors, and outcomes of delirium in Parkinson’s disease and atypical parkinsonism

    S. Green, A. McCleary, I. Sleeman, J. Maple-Grødem, C. Counsell, A. Macleod (Aberdeen, United Kingdom)

    Objective: To explore (i) the incidence of, (ii) the risk factors for, and (iii) the outcomes after, the first hospital episode of delirium in both…
  • « Previous Page
  • 1
  • …
  • 771
  • 772
  • 773
  • 774
  • 775
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley